R5U-18837-93318
2 vaccinations
1 coded response
17 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 488 / MI
- Registered
- 2021-07-29
- Relationship
- Self
- Race
- White
- Ethnicity
- N/A
Timeline
-
2021-07-09
Dose 1 — Pfizer-BioNTech
-
2021-07-29
Registered in v-safe
- 2021-07-29
-
2021-07-30
Dose 2 — Pfizer-BioNTech
- 2021-07-30
- 2021-07-31
- 2021-08-01
- 2021-08-02
- 2021-08-03
- 2021-08-04
- 2021-08-05
- 2021-08-06
- 2021-08-13
- 2021-08-20
-
2021-08-27
Survey response — day 28, dose 2MedDRA: Asthenia, Respiratory tract congestion, Rhinorrhoea — Feeling: FairFree text: Congested, running nose, lack of energyMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-09-03
- 2021-09-10
- 2021-10-29
- 2022-01-28
- 2022-07-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-09 | Pfizer-BioNTech | No |
| 2 | 2021-07-30 | Pfizer-BioNTech | No |
Free text
Release 9 — day 28, dose 2
Symptoms: Congested, running nose, lack of energy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthenia | ✓ | · | ✓ |
| SD | Respiratory tract congestion | ✓ | · | ✓ |
| SD | Rhinorrhoea | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release